Artificial Iris Implantation Appearance Or The Aftermath

Lydia Lee WRT 102.36 Becky Goldberg Research Paper April 22, 2015 Artificial Iris Implantation: Appearance or the Aftermath? When going out on a date, people usually dress up decently to present themselves as a charming individual. Besides fashionable clothing, most people groom themselves with the aid of cosmetic products that shows their concern for their facial appearances. Although most are satisfied with cosmetic disguises, some people want to appear to be more attractive by changing their appearance in perpetuity through cosmetic surgeries. As an important aspect of cosmetic surgeries, appearance enhancement is a major benefit that attracts most people to undergo the surgery. One cosmetic surgery that many have been longing for is†¦show more content†¦Different surgeries were found to reconstruct body deformities before the establishment of the American Association of Plastic Surgeons (AAPS) in 1921, mainly used to treat injured soldiers (Haiken 18). The AAPS is an organization that aims to improve the profession in plastic surgery. Subsequently, people began to raise concerns regarding the influence that these surgeries would have if they could be done on, besides medical, a cosmetic scheme. Eventually, the first nasal operation was done to improve an â€Å"exaggerated Roman nose,† followed by the rise of various cosmetic surgeries including artificial iris implantation (Haiken 20). More people began to create a budget for getting the surgery done. Most cosmetic surgeries derived from surgeries that were created for patient treatments. Artificial iris implantation becomes one of the surgeries that were suggested to perform cosmetically. In spite of receiving Conformità ©e Europà ©enne marking which allows the surgery to be operated in the European marketplace, the U.S. Food and Drug Administration (FDA) does not approve artificial iris implantation to be operated in the United States. With the clinical trials that have been performed, the results of the trials do not provide the FDA with the reason to approve the operation (Hoguet 392). As an agency within th e U.S. Department of Health and Human Services, the FDA is responsible for ensuring the health of the U.S. citizens. Given that the disapproval of the FDA,